IP Library Granted Patent US 7,029,659
Granted Patent B2
US 7,029,659 · App. 10/766,202 · Granted Apr 18, 2006

Mousse composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,029,659
App. No.
10/766,202
Granted
Apr 18, 2006
Kind
B2
Abstract

A topical mousse composition including an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.

Claims (51)

1. A topical mousse composition, the mousse composition comprising:

(a) an occlusive agent;

(b) an aqueous solvent; and

(c) an organic cosolvent;

wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.

2. The topical mousse composition according to claim 1 , wherein the occlusive agent comprises petrolatum.

3. The topical mousse composition according to claim 2 , wherein the occlusive agent further comprises a mineral oil and a long chain acid.

4. The topical mousse composition according to claim 1 , wherein the occlusive agent is selected from the group consisting of a mineral oil and grease, a long chain acid, an animal fat and grease, a vegetable fat and grease, and a water insoluble polymer.

5. The topical mousse composition according to claim 1 or 2 , wherein the occlusive agent is present in an amount of approximately 55% by weight or less, based on the total weight of the composition.

6. The topical mousse composition according to claim 5 , wherein the occlusive agent is present in an amount of approximately 10 to 50% by weight, based on the total weight of the composition.

7. The topical mousse composition according to claim 1 , further comprising an effective amount of an emulsifier component.

8. The topical mousse composition according to claim 7 , wherein the emulsifier component is present in an amount of from approximately 1% to 15% by weight, based on the total weight of the composition.

9. The topical mousse composition according to claim 7 , wherein the emulsifier component is present in an amount of from approximately 2% to 5% by weight, based on the total weight of the composition.

10. The topical mousse composition according to claim 7 , wherein the emulsifier component is selected from the group consisting of a non-ionic surfactant, a cationic surfactant, an anionic surfactant, a fatty alcohol, a fatty acid, and fatty acid salts thereof.

11. The topical mousse composition according to claim 10 , wherein the emulsifier component comprises a mixture of a sorbitan ester and a polyoxyethylene fatty alcohol ether.

12. The topical mousse composition according to claim 11 , wherein the emulsifier component further comprises a fatty alcohol, a fatty acid or a fatty acid salt.

13. The topical mousse composition according to claim 1 , wherein the aqueous solvent is present in an amount of approximately 25 to 95% by weight, based on the total weight of the composition.

14. The topical mousse composition according to claim 1 , wherein the organic cosolvent is present in an amount of approximately 0.25% by weight to 50% by weight, based on the total weight of the composition.

15. The topical mousse composition according to claim 1 , wherein the organic cosolvent is present in an amount of approximately 0.5% by weight to 2.0% by weight, based on the total weight of the composition.

16. The topical mousse composition according to claim 14 , wherein the organic cosolvent comprises an alkyl benzoate.

17. The topical mousse composition according to claim 14 , wherein the organic cosolvent is selected from the group consisting of an alkyl ether, an aromatic ether and a cyclic ether.

18. The topical mousse composition according to claim 1 , further comprising an effective amount of an aerosol propellant.

19. The topical mousse composition according to claim 18 , wherein the aerosol propellant is a hydrocarbon and is present in an amount of approximately 2.5 to 20% by weight, based on the total weight of the composition.

20. The topical mousse composition according to claim 1 , further comprising a water-insoluble pharmaceutically active ingredient.

21. The topical mousse composition according to claim 20 , wherein said water-insoluble pharmaceutically active ingredient is selected form the group consisting of an analgesic, an antifungal, an antibacterial, an anesthetic, an antiviral, an antipruritic, an antihistamine, a xanthine, a sex hormone, an anti-inflammatory, and a corticosteroid.

22. The topical mousse composition according to claim 21 , wherein said water-insoluble pharmaceutically active ingredient is an anti-inflammatory.

23. The topical mousse composition according to claim 20 , wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent.

24. The topical mousse composition according to claim 20 , wherein the pharmaceutically active ingredient is present in an amount of from approximately 0.005% by weight to approximately 10% by weight, based on the total weight of the composition.

25. The topical mousse composition according to claim 20 , wherein the pharmaceutically active ingredient is present in an amount of from approximately 0.05% by weight to approximately 1% by weight, based on the total weight of the composition.

26. A topical mousse composition, the mousse composition comprising:

(a) petrolatum in an amount of approximately 10 to 50% by weight, based on the total weight of the composition;

(b) an aqueous solvent; and

(c) an organic cosolvent.

27. The topical mousse composition according to claim 26 , further comprising an effective amount of an emulsifier component.

28. The topical mousse composition according to claim 26 , further comprising a water-insoluble pharmaceutically active ingredient.

29. The topical mousse composition according to claim 26 , wherein said water-insoluble pharmaceutically active ingredient is selected form the group consisting of an analgesic, an antifungal, an antibacterial, an anesthetic, an antiviral, an antipruritic, an antihistamine, xanthine, a sex hormone, an anti-inflammatory, and a corticosteroid.

30. The topical mousse composition according to claim 29 , wherein said water-insoluble pharmaceutically active ingredient is an anti-inflammatory.

31. A dispenser, the dispenser comprising:

a topical mousse composition comprising:

(a) an occlusive agent;

(b) an aqueous solvent; and

(c) an organic cosolvent;

wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.

32. The dispenser according to claim 31 , wherein said occlusive agent in said topical mousse composition comprises petrolatum.

33. The dispenser according to claim 31 , wherein said topical mousse composition further comprises an effective amount of an emulsifier component.

34. The dispenser according to claim 31 , wherein said topical mousse composition further comprises a water-insoluble pharmaceutically active ingredient.

35. The dispenser according to claim 31 , wherein said water-insoluble pharmaceutically active ingredient is selected from the group consisting of an analgesic, an antifungal, an antibacterial, an anesthetic, an antiviral, an antipruritic, an antihistamine, a xanthine, a sex hormone, an anti-inflammatory, and a corticosteroid.

36. The dispenser according to claim 35 , wherein said water-insoluble pharmaceutically active ingredient is an anti-inflammatory.

37. The topical mousse composition according to claim 21 , wherein said water-insoluble pharmaceutically active ingredient is a corticosteroid.

38. The topical mousse composition according to claim 29 , wherein said water-insoluble pharmaceutically active ingredient is a corticosteroid.

39. The dispenser according to claim 35 , wherein said water-insoluble pharmaceutically active ingredient is a corticosteroid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2013
From: STIEFEL RESEARCH AUSTRALIA PTY LTD
To: STIEFEL WEST COAST, LLC
Reel/Frame 030511/0963 →
CHANGE OF NAME Recorded Jun 2, 2009
From: CONNETICS AUSTRALIA PTY. LTD.
To: STIEFEL RESEARCH AUSTRALIA PTY LTD
Reel/Frame 022773/0140 →